Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
3(100.0%)
3Total
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05897372Phase 2Terminated

Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study

Role: lead

NCT06398002Phase 2Not Yet Recruiting

The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD

Role: lead

NCT06315504Not Yet Recruiting

Circulating Factors in Nephrotic Syndrome

Role: lead

NCT02977117Phase 2Completed

The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis

Role: lead

All 4 trials loaded